Janssen Biologics B.V.

Form 483 issued September 28, 2012 · Leiden, Netherlands

Inspection
Sep 20 – Sep 28, 2012
Investigator
Rebeca Rodriguez
Observations
2
Pages
1
FEI number
3002806632

In short: On September 28, 2012, FDA issued a Form 483 with 2 observations to Janssen Biologics B.V. in Leiden, Netherlands (FEI 3002806632) after an inspection that ran Sep 20 – Sep 28, 2012. The investigator was Rebeca Rodriguez. Most observations concern production and quality system.

At a glance

Production and quality system account for 2 of 2 observations.

Production1
Quality system1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Failure to conduct production operations in a manner that prevents microbial and endotoxin contamination…

  2. 02

    The Quality Unit failed to ensure that complete investigations are conducted and that corrective/preventive actions are…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Janssen Biologics B.V.?

FDA listed 2 observations on this Form 483, mostly about production and quality system. The opening words of each observation are shown on this page.

Who inspected Janssen Biologics B.V.?

Rebeca Rodriguez is named on this Form 483, for the inspection of Sep 20 – Sep 28, 2012. Each investigator has a profile showing what they cite most.

When was Janssen Biologics B.V. inspected by FDA?

The inspection ran Sep 20 – Sep 28, 2012, and the Form 483 is dated September 28, 2012.

How do I get the full Form 483 for Janssen Biologics B.V.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free